NCT00697346 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- groups
- description
- Alisertib 25 or 35 mg, Powder-in-Capsule (PIC) formulation, orally, once daily (QD) for 21 days followed by a 7-day recovery period in 28-day cycles or alisertib 35, 45, 65 or 90 mg PIC, orally, QD for 14 days followed by a 14-day recovery period in 28-day cycles, until disease progression or unacceptable alisertib-related toxicity (up to 14 cycles). All participants received an initial starting dosage of alisertib PIC 25 mg, orally, twice daily (BID) on Day 1 (loading dose), followed by their respective dosage assignment.
- id
- BG000
- title
- Part 1: PIC Dose Escalation
- description
- Alisertib 40 mg, Enteric-coated Tablet (ECT) formulation, orally, QD for 14 days followed by a 14-day recovery period in 28-day cycles, or alisertib 30, 40 or 50 mg ECT, orally BID for 7 days followed by a 14-day recovery period in 21-day cycles, until disease progression or unacceptable alisertib-related toxicity (up to 15 cycles).
- id
- BG001
- title
- Part 1: ECT Dose Escalation
- description
- Participants with peripheral T-cell lymphoma (PTCL) received alisertib 50 mg ECT, orally, BID for 7 days followed by a 14-day recovery period in 21-day cycles, until disease progression or unacceptable alisertib-related toxicity (up to 2 cycles).
- id
- BG002
- title
- Part 2: PTCL
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.91
- value
- 61.4
- group Id
- BG001
- spread
- 14.22
- value
- 59.5
- group Id
- BG002
- spread
- 24.04
- value
- 63.0
- group Id
- BG003
- spread
- 12.03
- value
- 60.5
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 31
- title
- Female
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 27
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 16
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 41
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 52
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 4
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- title
- Not Reported
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.25
- value
- 165.9
- group Id
- BG001
- spread
- 10.95
- value
- 164.6
- group Id
- BG002
- spread
- 6.43
- value
- 160.6
- group Id
- BG003
- spread
- 10.89
- value
- 165.1
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 56
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- Here number analyzed is the number of participants who were evaluated for height at baseline.
- title
- Height
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 20.031
- value
- 81.40
- group Id
- BG001
- spread
- 19.747
- value
- 77.62
- group Id
- BG002
- spread
- 43.911
- value
- 97.65
- group Id
- BG003
- spread
- 20.573
- value
- 80.13
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.282
- value
- 1.93
- group Id
- BG001
- spread
- 0.289
- value
- 1.88
- group Id
- BG002
- spread
- 0.434
- value
- 2.05
- group Id
- BG003
- spread
- 0.286
- value
- 1.91
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 56
- units
- Participants
- description
- Body Surface Area =square root \[height (cm) \* weight (kg) / 3600\].
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- Here number analyzed is the number of participants who were evaluated for body surface area at baseline.
- title
- Body Surface Area
- unit Of Measure
- m^2
- population Description
- Safety population is defined as all participants who received any amount of alisertib.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- groups
- description
- Alisertib 25 or 35 mg, Powder-in-Capsule (PIC) formulation, orally, once daily (QD) for 21 days followed by a 7-day recovery period in 28-day cycles or alisertib 35, 45, 65 or 90 mg PIC, orally, QD for 14 days followed by a 14-day recovery period in 28-day cycles, until disease progression or unacceptable alisertib-related toxicity (up to 14 cycles). All participants received an initial starting dosage of alisertib PIC 25 mg, orally, twice daily (BID) on Day 1 (loading dose), followed by their respective dosage assignment.
- id
- BG000
- title
- Part 1: PIC Dose Escalation
- description
- Alisertib 40 mg, Enteric-coated Tablet (ECT) formulation, orally, QD for 14 days followed by a 14-day recovery period in 28-day cycles, or alisertib 30, 40 or 50 mg ECT, orally BID for 7 days followed by a 14-day recovery period in 21-day cycles, until disease progression or unacceptable alisertib-related toxicity (up to 15 cycles).
- id
- BG001
- title
- Part 1: ECT Dose Escalation
- description
- Participants with peripheral T-cell lymphoma (PTCL) received alisertib 50 mg ECT, orally, BID for 7 days followed by a 14-day recovery period in 21-day cycles, until disease progression or unacceptable alisertib-related toxicity (up to 2 cycles).
- id
- BG002
- title
- Part 2: PTCL
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.91
- value
- 61.4
- group Id
- BG001
- spread
- 14.22
- value
- 59.5
- group Id
- BG002
- spread
- 24.04
- value
- 63.0
- group Id
- BG003
- spread
- 12.03
- value
- 60.5
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 31
- title
- Female
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 27
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 16
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 41
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 52
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 4
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- title
- Not Reported
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.25
- value
- 165.9
- group Id
- BG001
- spread
- 10.95
- value
- 164.6
- group Id
- BG002
- spread
- 6.43
- value
- 160.6
- group Id
- BG003
- spread
- 10.89
- value
- 165.1
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 56
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- Here number analyzed is the number of participants who were evaluated for height at baseline.
- title
- Height
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 20.031
- value
- 81.40
- group Id
- BG001
- spread
- 19.747
- value
- 77.62
- group Id
- BG002
- spread
- 43.911
- value
- 97.65
- group Id
- BG003
- spread
- 20.573
- value
- 80.13
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 58
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.282
- value
- 1.93
- group Id
- BG001
- spread
- 0.289
- value
- 1.88
- group Id
- BG002
- spread
- 0.434
- value
- 2.05
- group Id
- BG003
- spread
- 0.286
- value
- 1.91
- denoms
- counts
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 56
- units
- Participants
- description
- Body Surface Area =square root \[height (cm) \* weight (kg) / 3600\].
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- Here number analyzed is the number of participants who were evaluated for body surface area at baseline.
- title
- Body Surface Area
- unit Of Measure
- m^2
- population Description
- Safety population is defined as all participants who received any amount of alisertib.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle